Giovanni Bellomo

University of Perugia

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (12)

Lucilla Parnetti

Professor of Neurology

University of Perugia

Davide Chiasserini

Associate Professor

University of Perugia

Flavia Prodam

Roccaldo Sardella

Lorenzo Barba

Martin Luther University Halle-Wittenberg

Markus Otto

Lisa Vermunt

University of Amsterdam

Alberto Rábano

Head of Neuropathology

Nina Morgner

Heisenberg Professor (Physikalische und Theoretische Chemie)

Lorenzo Gaetani

University of Perugia

Francesca Riuzzi

University of Perugia

Cinzia ANTOGNELLI

University of Perugia

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giovanni Bellomo

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (12)

Lucilla Parnetti

Davide Chiasserini

Flavia Prodam

Roccaldo Sardella

Lorenzo Barba

Markus Otto

Lisa Vermunt

Alberto Rábano

Nina Morgner

Lorenzo Gaetani

Francesca Riuzzi

Cinzia ANTOGNELLI

Make your next move.

Giovanni Bellomo

Research Interests

Explore related searches

Contact this professor

Articles (20)

Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease

Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease

Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers

Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized <i>Vaccinium macrocarpon</i> Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy

Identifying Patients With Synucleinopathies

Diagnostic performance of plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non‐AD dementias: An international multi‐center study

Fully automated measurement of plasma Aβ42/40 and p‐tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts

Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay

Advances in Diagnosis and Prognosis of Parkinson Disease: Value of Cerebrospinal Fluid Proteomics [re: WNL-2023-000508]

CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease

On the Track of α-Synuclein in the Body

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions

Modulation of Aβ42 Aggregation Kinetics and Pathway by Low‐Molecular‐Weight Inhibitors

Advances in Diagnosis and Prognosis of Parkinson Disease

CSF neurochemical profile and cognitive changes in Parkinson’s disease with mild cognitive impairment

Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays

A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias

α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies

Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer’s Disease

Collaborators (12)

Lucilla Parnetti

Davide Chiasserini

Flavia Prodam

Roccaldo Sardella

Lorenzo Barba

Markus Otto

Lisa Vermunt

Alberto Rábano

Nina Morgner

Lorenzo Gaetani

Francesca Riuzzi

Cinzia ANTOGNELLI

Make your next move.